Literature DB >> 34792780

AST-to-ALT ratio and coronary artery lesions among patients with Kawasaki disease.

Lei Cao1, Yun-Jia Tang1, Miao Gang1, Jin Ma2, Wei-Guo Qian1, Qiu-Qin Xu1, Hai-Tao Lv3.   

Abstract

BACKGROUND: The aim of this study was to explore the associations between the aspartate aminotransferase-to-alanine aminotransferase ratio (AST/ALT) and coronary artery lesions (CALs) among patients with Kawasaki disease (KD).
METHODS: Medical records of KD patients presenting to a single center between January 2019 and December 2020 were retrospectively collected and analyzed. Univariate, multivariable-adjusted analyses, subgroup analyses, restricted cubic spline test, and fitted curves were used to evaluate the associations between AST/ALT and CALs.
RESULTS: A total of 831 patients were enrolled, of which 201 (24.2%) had CALs on admission and 21 (2.5%) developed CALs de novo after intravenous immunoglobulin (IVIG). Multivariable-adjusted analyses models revealed that a lower AST/ALT was associated with an increased risk of CALs on admission when AST/ALT was a continuous variable (P = 0.007) and when it was a categorical variable (P for trend = 0.004). Each unit increase in AST/ALT was associated with a 22% lower risk of CALs on admission (odds ratio = 0.78, 95% confidence interval 0.65-0.94). A negative linear relationship was noted between AST/ALT and the risk of CALs on admission in both observed and fitted models. However, such associations were not observed in AST/ALT and CALs de novo after IVIG. None of the variables significantly modified the association between AST/ALT and CALs on admission and CALs de novo after IVIG (P > 0.05).
CONCLUSION: Our findings suggested that AST/ALT was a risk factor of CALs, but was not associated with progressive CALs.
© 2021. Children's Hospital, Zhejiang University School of Medicine.

Entities:  

Keywords:  Alanine aminotransferase; Aspartate aminotransferase; Coronary artery lesions; Kawasaki disease

Mesh:

Substances:

Year:  2021        PMID: 34792780     DOI: 10.1007/s12519-021-00479-0

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  3 in total

1.  Usefulness of brain natriuretic peptide to distinguish Kawasaki disease from cervical lymphadenitis.

Authors:  Taichiro Muto; Yu Masuda; Nami Nakamura; Shingo Numoto; Shunsuke Kodama; Ryosuke Miyamoto; Kenji Miyata; Tomohito Hayakawa; Hiromitsu Mori; Yoshiyuki Kuroyanagi; Mitsuko Akaihata; Hideyuki Iwayama; Hirokazu Kurahashi; Yasuhito Shimomura; Takuhito Nagai; Toshinori Hori; Hiroatsu Agata; Akihisa Okumura
Journal:  Pediatr Int       Date:  2021-11-05       Impact factor: 1.524

2.  Observation of Kawasaki disease-related indexes and the study of relationship between myocardial enzyme changes and coronary artery lesions.

Authors:  L Niu; X J An; M Y Fu; X H He; Q W Wang
Journal:  Eur Rev Med Pharmacol Sci       Date:  2015-11       Impact factor: 3.507

3.  Association between Alanine Aminotransferase/Aspartate Aminotransferase Ratio (AST/ALT Ratio) and Coronary Artery Injury in Children with Kawasaki Disease.

Authors:  Jinxin Wang; Jiawen Li; Yue Ren; Hongying Shi; Xing Rong; Xuting Zhang; Yiping Shao; Rongzhou Wu; Maoping Chu; Huixian Qiu
Journal:  Cardiol Res Pract       Date:  2020-03-23       Impact factor: 1.866

  3 in total
  1 in total

Review 1.  Clinical Manifestations and Laboratory Findings of Kawasaki Disease: Beyond the Classic Diagnostic Features.

Authors:  Wendy Lee; Chooi San Cheah; Siti Aisyah Suhaini; Abdullah Harith Azidin; Mohammad Shukri Khoo; Noor Akmal Shareela Ismail; Adli Ali
Journal:  Medicina (Kaunas)       Date:  2022-05-30       Impact factor: 2.948

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.